The Next Blockbuster - You Decide!

CNN Money reports that "After a rough couple of years dealing with patent expirations and the often frustrating hunt for new products, drug industry executives would love nothing better than an oracle to predict what products in their labs will become the big blockbuster drugs over the next few years."

I'd like to try a "wisdom of the crowd" experiment and see if readers of Pharma Marketing Blog may be the oracle sought by the industry. So, the contenders for blockbusters and a bit of information about them are presented in today's post to Pharma Marketing Blog, where you can vote on which ones you think will achieve blockbuster status over the next few years.

See today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

• Legal/Regulatory
• Sales & Sales Reps

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

The collection of articles and commentary in this first Pharma Marketing News Special Supplement chronicles the emerging issues of direct-to-consumer (DTC) advertising and presents pro and con opinions from experts on how DTC needs to adapt in the post-Vioxx marketing era. Topics include: DTC Pros and Cons, Straight-Talking DTC, Communicating Risk, Biotech DTC, Print DTC, and more.

TABLE OF CONTENTS

Order and pay for Volume One now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form